Wooster et al., [55] reported that ACE2 rs4240157 polymorphisms is associated with COVID-19 disease severity as it might be inducing higher tissue specific expression of ACE2 resulting in the hospitalization of COVID-19 patients. This evidence concerns the gene ACE2 and COVID-19.